XM does not provide services to residents of the United States of America.

Swiss stocks - Factors to watch on April 16



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Swiss stocks - Factors to watch on April 16</title></head><body>

ZURICH/BERLIN, April 16 (Reuters) -Here are some of the main factors that may affect Swiss stocks on Tuesday:


UBS UBSG.S

Estimates that Swiss bank UBS will require another $15 billion to $25 billion in capital under government proposals aimed at making the banking sector more robust are broadly right, Swiss Finance Minister Karin Keller-Sutter was quoted as saying on Tuesday.


SIKA AG SIKA.S

Swiss chemicals maker Sika AG on Tuesday reported a 13.8% increase in its first-quarter sales and confirmed its outlook for 2024.


NOVARTIS NOVN.S

Novartis said on Monday new Novartis Fabhalta data showed clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy.

COMPANY STATEMENTS


DOCMORRIS AG DOCM.S

First-quarter results due.


SULZER AG SUN.S

Annual General Meeting 2024 due.


ANALYSTS' VIEWS

SGS SA SGSN.S: JP MORGAN RAISES TO OVERWEIGHT FROM NEUTRAL


EX-DIVIDEND

STRAUMANN AG STMN.S - 0.85 CHF/shr dividend

ECONOMY

No major Swiss economic data scheduled.



Reporting by Zurich newsroom and Berlin Speed Desk

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.